Gary Lichtenstein, MD

University of Pennsylvania

Poster(s):

• E0391 - The Effect of Guselkumab Induction Therapy on Inflammatory Biomarkers in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Results Through Week 12
  Tuesday, October 25, 2022

  3:00 PM – 5:00 PM ET